Acrivon Therapeutics, Inc. · NASDAQ:ACRV

Gamelin Erick sold 416 Acrivon Therapeutics, Inc. shares (Form 4)

Traded Nov 17, 2026 · Filed Nov 19, 2026

On Nov 17, 2026, Gamelin Erick (Chief Development Officer) sold 416 Acrivon Therapeutics, Inc. shares at US$1.45 for US$603, leaving 52,176 shares. Filed Nov 19, 2026 (Form 4).

Sold
416 shares
Price
US$1.45
Value
US$603
Holding after
52,176 shares
Trading plan
No
Role
Chief Development Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 17, 2026Common StockSale416US$1.4552,176Direct

Source

Download original · View original at SEC

Related